-
100-Fold Increase in Weight Loss Drug Prescription Period Prevalence in Active-Duty Military
28 May 2025 14:05 GMT
… -term therapies: liraglutide, lorcaserin, naltrexone/bupropion, … covered medications following U.S. Food and Drug … introduction of semaglutide following FDA approval in June 2021 … aware of treatment options involving these medications.”
Differences between …
-
Dravet Syndrome Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies By Delveinsight
26 May 2025 13:26 GMT
… drug (IND) application for ETX101, allowing the company to initiate clinical trials … Pharmaceuticals, and others
Key Dravet Syndrome Therapies: TAK-935 (soticlestat), BELVIQ (lorcaserin … Syndrome treatment includes antiepileptic medications like stiripentol …
-
The dark side of slimming down: A 100-year journey of weight loss drugs
20 May 2025 16:19 GMT
… drugs
Weight loss drugs have long occupied a complicated space in medicine … : Renewed Approvals Amid Caution
Lorcaserin, approved in 2012, worked … the FDA in 2020 after a randomized controlled trial showed … The future of obesity treatment is promising—but it …
-
Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)
20 Feb 2025 22:50 GMT
… Drug Administration (FDA) is alerting the public that results from a clinical trial … about your medical treatment.
Lorcaserin is a prescription medicine approved by FDA in 2012 … XR).
When approving lorcaserin, we required the drug manufacturer, Eisai Inc …
-
FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market
20 Feb 2025 19:46 GMT
… (CAMELLIA-TIMI 61) clinical trial. It was a randomized … , multicenter, parallel group trial conducted between January 2014 and … trial, 462 (7.7 percent) patients treated with lorcaserin … treatment, but the imbalance increased with longer duration on lorcaserin.
-
Eisai Closes Door on Lorcaserin Program for Dravet Syndrome
02 Dec 2024 21:25 GMT
… discontinued 2 clinical trials for lorcaserin in Dravet syndrome … lorcaserin as an effective antiseizure treatment after other medications failed.
Issues with the trial … FDA-approved weight-loss drug. In February 2020, Eisai voluntarily withdrew the medication …
-
Eisai terminates Phase 3 trial of Dravet drug lorcaserin
17 Nov 2024 18:21 GMT
-
Eisai terminates Phase 3 trial of Dravet drug lorcaserin
17 Nov 2024 10:44 GMT
-
A Randomized Controlled Trial of Lorcaserin in Cocaine Use Disorder
07 Oct 2024 19:17 GMT
… US Food and Drug Administration-approved medications for the treatment of CUD, and … , placebo-controlled trial of lorcaserin in cocaine use disorder. Drug Alcohol Depend. 2024 … with lorcaserin – The FDA’s review of the CAMELLIA-TIMI 61 trial. N …
-
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
16 Oct 2024 13:20 GMT
… biotechnology company focused on developing novel drugs for the targeted treatment … Food and Drug Administration (FDA)- approved … pharmaceutical companies engaged in drug research and clinical trials, as well as medical … tests. Compared to Lorcaserin, BMB-101 …
About
© 1995-2025